- Abrahamsson PA (1999): Neuroendocrine differentiation in prostatic carcinoma. Prostate 39:135-148.
- Ahlgren G, Pedersen K, Lundberg S, Aus G, Hugosson J, Abrahemsson PA (2000): Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate 42:274-279.
- Berruti A, Dogliotii L, Mosca A (2000): Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer 88:2590-2596.
- Bjork T, Ljungberg B, Piironen T, Abrahamsson P, Pettersson K, Cockett ATK (1998): Rapid exponential elimination of free prostate specific antigen contrasts the slow capacity-limited elimination of PSA complexed to alpha-1-antichymotrypsin from serum. Urology 51:57-62.
- Bonkhoff H (1998): Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation and androgen receptor status. Prostate (suppl) 8:18-22.
- Brandle E, Hautmann O, Bachem M (1999): Serum half-life time determination of free and total prostate specific antigen following radical prostatectomy: a critical assessment. Urology 53:722-730.
- Casella R, Budendorf L, Sauter G, Moch H, Mihatsch MJ, Gasser TC (1998): Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. J Urol 160:406-410.
- Cohen RJ (1991): Neuroendocrine cells: a new prognostic parameter in prostate cancer. Br J Urol 68:258-262.
- Di Sant' Agnese PA (1992): Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268.
- Helpap B, Kollermann J, Oehler U (1999): Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance and future therapeutic perspectives. Urol Int 62:133-138.
- Kanno T, Asada N, Yanase H, Iwanaga T, Ozaki T (1999): Salivary secretion of highly concentrated chromogranin A in response to noradrenaline and acetylcholine in isolated and perfused rat submandibular glands. Exp Physiol 84:1073-1083.
- Krijnen J, Jansen P, Ruizeveld de Winter JA, van Kimpen H, Schroeder F, van der Kwast T (1993): Do neuroendocrine cells in human prostate cancer express androgen receptors? Histochemistry 100:393-398.
- Krupski T, Petroni GR, Frierson HF (2000): Microvessel density, p53, retinoblastoma and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate. Urology 55:743-749.
- Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT (2001): Proteolytic cleavage of chromogranin A by plasmin: selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem 276:25022-25029.
- Lilja H, Haese A, Bjork T, Friedrich MG, Piironen T (1999): Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy. J Urol 162:2029-2035.
- Moftaquir-Handaj A, Barbe F, Barbarino-Monnier P (1995): Circulating chromogranin A and catecholamines in human fetuses at uneventful birth. Pediatr Res 37:101-105.
- Monti S, Sciarra A, Falasca P, Di Silverio F (2000): Serum concentrations and prostatic gene expression of chromogranin A and PSA in patients affected by prostate cancer and benign prostatic hyperplasia. J Endocrin Invest 23 (suppl 8):53.
- O'Connor DT, Bernstein KN (1984): Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311:764-770.
- Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzel DJ, Walsh PC (1998): Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766-772.
- Partin AW, Piantadosi S, Subong ENP, Kelly CA, Hortopan S, Chan DW (1996) Clearance rate of serum free and total PSA following radical retropubic prostatectomy. Prostate (suppl) 7:35-39.
- Sanchez-Margalet V, Goberna R (1993): Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat. Peptides 14:797-799.
- Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS (1987): Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909-916.
- UICC (1997): TNM Klassification Maligner Tumoren, ed 5. Berlin: Springer.
VARIATION OF CHROMOGRANIN A SERUMLEVELS AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE ADENOCARCINOMA
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.